71655-578-08 : NDC 2026 Code

71655-578-08 : Ansuvimab ( Ebanga )

Additionally :

You can get information about “71655-578-08” NDC code in 71655-578-08 in HTML format

HTML | 71655-578-08 in TXT (Plain Text) format

TXT | 71655-578-08 in PDF (Portable Document Format)

PDF | 71655-578-08 in XML format

XML formats.

NDC Code : 71655-578-08 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "71655-578-08",
    "PackageDescription": "8 CARTON in 1 BOX (71655-578-08)  / 36 VIAL, GLASS in 1 CARTON (71655-578-02)  / 8 mL in 1 VIAL, GLASS (71655-578-01) ",
    "NDC11Code": "71655-0578-08",
    "ProductNDC": "71655-578",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Ebanga",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Ansuvimab",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20201221",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761172",
    "LabelerName": "Emergent Manufacturing Operations Baltimore, LLC",
    "SubstanceName": "ANSUVIMAB",
    "StrengthNumber": "400",
    "StrengthUnit": "mg/8mL",
    "Pharm_Classes": "Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA], Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-01-18",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20201221",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}